Literature DB >> 23988430

The sodium/iodide symporter: state of the art of its molecular characterization.

Elisabeth Darrouzet1, Sabine Lindenthal, Didier Marcellin, Jean-Luc Pellequer, Thierry Pourcher.   

Abstract

The sodium/iodide symporter (NIS or SLC5A5) is an intrinsic membrane protein implicated in iodide uptake into thyroid follicular cells. It plays a crucial role in iodine metabolism and thyroid regulation and its function is widely exploited in the diagnosis and treatment of benign and malignant thyroid diseases. A great effort is currently being made to develop a NIS-based gene therapy also allowing the radiotreatment of nonthyroidal tumors. NIS is also expressed in other tissues, such as salivary gland, stomach and mammary gland during lactation, where its physiological role remains unclear. The molecular identity of the thyroid iodide transporter was elucidated approximately fifteen years ago. It belongs to the superfamily of sodium/solute symporters, SSS (and to the human transporter family, SLC5), and is composed of 13 transmembrane helices and 643 amino acid residues in humans. Knowledge concerning NIS structure/function relationship has been obtained by taking advantage of the high resolution structure of one member of the SSS family, the Vibrio parahaemolyticus sodium/galactose symporter (vSGLT), and from studies of gene mutations leading to congenital iodine transport defects (ITD). This review will summarize current knowledge regarding the molecular characterization of NIS.
© 2013.

Entities:  

Keywords:  Membrane protein; NIS; SLC5A5; Sodium/iodide symporter; Structure/function relationship; Thyroid

Mesh:

Substances:

Year:  2013        PMID: 23988430     DOI: 10.1016/j.bbamem.2013.08.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

Review 1.  Drugs in Lactation.

Authors:  Philip O Anderson
Journal:  Pharm Res       Date:  2018-02-06       Impact factor: 4.200

2.  N-Acetyl-L-cysteine protects thyroid cells against DNA damage induced by external and internal irradiation.

Authors:  Tomomi Kurashige; Mika Shimamura; Yuji Nagayama
Journal:  Radiat Environ Biophys       Date:  2017-09-04       Impact factor: 1.925

Review 3.  Modulation of sodium iodide symporter in thyroid cancer.

Authors:  Aparna Lakshmanan; Daniel Scarberry; Daniel H Shen; Sissy M Jhiang
Journal:  Horm Cancer       Date:  2014-09-19       Impact factor: 3.869

Review 4.  Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine.

Authors:  Stefania Bulotta; Marilena Celano; Giuseppe Costante; Diego Russo
Journal:  Endocrine       Date:  2015-12-21       Impact factor: 3.633

5.  Mapping of Ion and Substrate Binding Sites in Human Sodium Iodide Symporter (hNIS).

Authors:  Hristina R Zhekova; Toshie Sakuma; Ryan Johnson; Susanna C Concilio; Patrycja J Lech; Igor Zdravkovic; Mirna Damergi; Lukkana Suksanpaisan; Kah-Whye Peng; Stephen J Russell; Sergei Noskov
Journal:  J Chem Inf Model       Date:  2020-03-12       Impact factor: 4.956

6.  Exposure to Radiocontrast Agents Induces Pancreatic Inflammation by Activation of Nuclear Factor-κB, Calcium Signaling, and Calcineurin.

Authors:  Shunqian Jin; Abrahim I Orabi; Tianming Le; Tanveer A Javed; Swati Sah; John F Eisses; Rita Bottino; Jeffery D Molkentin; Sohail Z Husain
Journal:  Gastroenterology       Date:  2015-05-14       Impact factor: 22.682

7.  High-Throughput Screening and Quantitative Chemical Ranking for Sodium-Iodide Symporter Inhibitors in ToxCast Phase I Chemical Library.

Authors:  Jun Wang; Daniel R Hallinger; Ashley S Murr; Angela R Buckalew; Steven O Simmons; Susan C Laws; Tammy E Stoker
Journal:  Environ Sci Technol       Date:  2018-04-11       Impact factor: 9.028

8.  Polyhydrazide-Based Organic Nanotubes as Efficient and Selective Artificial Iodide Channels.

Authors:  Arundhati Roy; Himanshu Joshi; Ruijuan Ye; Jie Shen; Feng Chen; Aleksei Aksimentiev; Huaqiang Zeng
Journal:  Angew Chem Int Ed Engl       Date:  2020-02-04       Impact factor: 15.336

9.  A comparison of thyroidal protection by iodine and perchlorate against radioiodine exposure in Caucasians and Japanese.

Authors:  A Rump; S Eder; C Hermann; A Lamkowski; M Kinoshita; T Yamamoto; M Abend; N Shinomiya; M Port
Journal:  Arch Toxicol       Date:  2021-05-18       Impact factor: 5.153

10.  Analysis Natrium Iodide Symporter Expression in Breast Cancer Subtypes for Radioiodine Therapy Response.

Authors:  Aisyah Elliyanti; Dewi Rusnita; Nita Afriani; Yayi Dwina Billianti Susanto; Veronica Y Susilo; Sri Setiyowati; Wirsma Arif Harahap
Journal:  Nucl Med Mol Imaging       Date:  2020-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.